Whereas, serum RBP4 levels were positively associated with breast cancer risk among subjects with lower BMI (<25 kg/m2) (multivariable OR = 2.72, 95% CI = 1.09 to 6.79 for second versus lowest tertile). This evidence concerns the gene RBP4 and breast carcinoma.